ロード中...
Pharmaceutical supply chain risks: a systematic review
INTRODUCTION: Supply of medicine as a strategic product in any health system is a top priority. Pharmaceutical companies, a major player of the drug supply chain, are subject to many risks. These risks disrupt the supply of medicine in many ways such as their quantity and quality and their delivery...
保存先:
| 主要な著者: | , , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
BioMed Central
2013
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3913399/ https://ncbi.nlm.nih.gov/pubmed/24355166 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/2008-2231-21-69 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|